SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Short Candidates -- Ignore unavailable to you. Want to Upgrade?


To: tuck who wrote (158)12/27/2001 10:14:03 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 897
 
I was joking. The "red wine study" showed an effect reducing endothelin-1 synthesis, and Texas Bio is hot on endothelin-1 receptor antagonists.

>> You consider Chalone's offerings more efficacious, I gather. <<

I don't know much about the projects, but when I last looked, the ICOS collaboration was serious stuff. So.... no, not by any means (but from a naive stance).